Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP).
Sakata Y, Saito G, Sakata S, Oya Y, Tamiya M, Suzuki H, Shibaki R, Okada A, Yokoyama T, Matsumoto H, Otsuki T, Sato Y, Junji U, Tsukita Y, Inaba M, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Morinaga J, Sakagami T. Sakata Y, et al. Among authors: ikeda h. Lung Cancer. 2023 Dec;186:107426. doi: 10.1016/j.lungcan.2023.107426. Epub 2023 Nov 19. Lung Cancer. 2023. PMID: 37992594
Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study.
Imaji M, Fujimoto D, Sato Y, Sakata Y, Oya Y, Tamiya M, Suzuki H, Ikeda H, Kijima T, Matsumoto H, Kanazu M, Hino A, Inaba M, Tsukita Y, Arai D, Maruyama H, Hara S, Tsumura S, Kobe H, Sumikawa H, Sakata S, Yamamoto N. Imaji M, et al. Among authors: ikeda h. Eur J Cancer. 2023 Jan;179:15-24. doi: 10.1016/j.ejca.2022.10.029. Epub 2022 Nov 12. Eur J Cancer. 2023. PMID: 36470023
Corrigendum to "Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT-EP)" [Lung Cancer 186 (2023) 107426].
Sakata Y, Saito G, Sakata S, Oya Y, Tamiya M, Suzuki H, Shibaki R, Okada A, Yokoyama T, Matsumoto H, Otsuki T, Sato Y, Junji U, Tsukita Y, Inaba M, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Morinaga J, Sakagami T. Sakata Y, et al. Among authors: ikeda h. Lung Cancer. 2024 Feb;188:107450. doi: 10.1016/j.lungcan.2023.107450. Epub 2023 Dec 30. Lung Cancer. 2024. PMID: 38160082 No abstract available.
[Pulmonary nocardiosis--statistical analysis in Japan].
Kaneko T, Matsumoto H, Ikeda H, Ito A, Okubo T. Kaneko T, et al. Among authors: ikeda h. Kansenshogaku Zasshi. 1987 May;61(5):606-14. doi: 10.11150/kansenshogakuzasshi1970.61.606. Kansenshogaku Zasshi. 1987. PMID: 3117948 Japanese. No abstract available.
Associations between day-by-day variability in blood pressure measured at home and antihypertensive drugs: the J-HOME-Morning study.
Ishikura K, Obara T, Kato T, Kikuya M, Shibamiya T, Shinki T, Ikeda U, Kobayashi Y, Metoki H, Mano N, Kuriyama S, Ohkubo T, Imai Y; J-HOME-Morning Study Group. Ishikura K, et al. Among authors: ikeda u. Clin Exp Hypertens. 2012;34(4):297-304. doi: 10.3109/10641963.2012.681087. Epub 2012 May 7. Clin Exp Hypertens. 2012. PMID: 22564087 Free article.
Syntheses of apogalanthamine analogs as alpha-adrenergic blocking agents.
Kobayashi S, Kihara M, Shizu S, Katayama S, Ikeda H, Kitahiro K, Matsumoto H. Kobayashi S, et al. Among authors: ikeda h. Chem Pharm Bull (Tokyo). 1977 Dec;25(12):3312-23. doi: 10.1248/cpb.25.3312. Chem Pharm Bull (Tokyo). 1977. PMID: 24504 No abstract available.
Health Utility of Pain Response Versus Nonresponse to Palliative Radiation Therapy for Symptomatic Bone Metastases: Analyses Based on Real-World Data from 26 Centers.
Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, Notsu A, Shirato H, Yamada K, Uezono H, Koide Y, Kubota H, Yamazaki T, Ito K, Heianna J, Okada Y, Tonari A, Katoh N, Wada H, Ejima Y, Yoshida K, Kosugi T, Takahashi S, Komiyama T, Uchida N, Miwa M, Watanabe M, Nagakura H, Ikeda H, Asakawa I, Shigematsu N. Saito T, et al. Among authors: ikeda h. J Palliat Med. 2024 Dec 27. doi: 10.1089/jpm.2024.0208. Online ahead of print. J Palliat Med. 2024. PMID: 39729365
4,519 results